Carlos Bacino, MD, FACMG

Carlos Bacino, MD | Image Credit: Baylor College of Medicine

Carlos Bacino, MD, is the medical director of the cytogenetics laboratory at Baylor Genetics.

Articles by Carlos Bacino, MD, FACMG

Recognizing and Diagnosing Achondroplasia

ByTeresa Quattrin, MD,Ricki Carroll, MD,Carlos Bacino, MD, FACMG

September 17th 2026

Characteristic clinical and radiographic findings can establish early suspicion for achondroplasia, while molecular and prenatal testing are helping clinicians confirm the diagnosis sooner.

Understanding the Pathophysiology of Achondroplasia

ByTeresa Quattrin, MD,Ricki Carroll, MD,Carlos Bacino, MD, FACMG

September 17th 2026

Achondroplasia is driven by overactive FGFR3 signaling that disrupts normal growth plate function. The panel explains how this molecular pathway affects endochondral bone growth and provides the foundation for understanding targeted treatment.

Once-Weekly Navepegritide Safe and Efficacious for Achondroplasia, With Carlos Bacino, MD

ByCarlos Bacino, MD, FACMG

April 15th 2026

Bacino highlights the recently approved treatment’s safety data and emphasizes the likelihood of increased adherence due to longer intervals between administration.